ALPS Advisors’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $465K | Sell |
57,086
-20,021
| -26% | -$163K | ﹤0.01% | 652 |
|
|
2025
Q1 | $605K | Buy |
77,107
+3,112
| +4% | +$24.4K | ﹤0.01% | 568 |
|
|
2024
Q4 | $1.1M | Buy |
73,995
+5,633
| +8% | +$83.9K | 0.01% | 462 |
|
|
2024
Q3 | $1.05M | Sell |
68,362
-2,586
| -4% | -$39.5K | 0.01% | 482 |
|
|
2024
Q2 | $1.08M | Buy |
70,948
+6,858
| +11% | +$104K | 0.01% | 449 |
|
|
2024
Q1 | $1.21M | Buy |
64,090
+11,619
| +22% | +$219K | 0.01% | 429 |
|
|
2023
Q4 | $1M | Sell |
52,471
-2,480
| -5% | -$47.4K | 0.01% | 483 |
|
|
2023
Q3 | $986K | Buy |
54,951
+1,214
| +2% | +$21.8K | 0.01% | 451 |
|
|
2023
Q2 | $1.09M | Buy |
53,737
+5,637
| +12% | +$114K | 0.01% | 472 |
|
|
2023
Q1 | $877K | Sell |
48,100
-675
| -1% | -$12.3K | 0.01% | 495 |
|
|
2022
Q4 | $1.01M | Buy |
48,775
+9,400
| +24% | +$194K | 0.01% | 480 |
|
|
2022
Q3 | $1.03M | Sell |
39,375
-3,174
| -7% | -$83K | 0.01% | 460 |
|
|
2022
Q2 | $1.08M | Sell |
42,549
-30,491
| -42% | -$773K | 0.01% | 463 |
|
|
2022
Q1 | $2.31M | Sell |
73,040
-8,255
| -10% | -$261K | 0.03% | 188 |
|
|
2021
Q4 | $3.29M | Sell |
81,295
-6,208
| -7% | -$251K | 0.04% | 184 |
|
|
2021
Q3 | $3.05M | Sell |
87,503
-6,003
| -6% | -$209K | 0.03% | 219 |
|
|
2021
Q2 | $2.57M | Sell |
93,506
-23,945
| -20% | -$658K | 0.02% | 251 |
|
|
2021
Q1 | $3.3M | Buy |
117,451
+133
| +0.1% | +$3.74K | 0.03% | 206 |
|
|
2020
Q4 | $3.05M | Buy |
+117,318
| New | +$3.05M | 0.03% | 214 |
|